Abstract:Background Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that specifically occurs in pregnancy. Elevated levels of liver transaminases aspartate aminotransferase, alanine aminotransferase and serum bilirubin levels are common biochemical characteristics in ICP. The disorder is associated with an increased risk of premature delivery and stillbirth. The characterization of the potential microbiota in ICP could go a long way in the prevention and treatment of this pregnancy disease. Methods A total of 58 patients were recruited for our study: 27 ICP patients and 31 healthy pregnant subjects with no ICP. The V3 and V4 regions of the 16S rDNA collected from fecal samples of both diseased and control groups were amplified. 16S rRNA gene amplicon sequencing was then performed on gut microbiota. Sequencing data were analyzed and the correlation between components of microbiota and patient ICP status was found. Related metabolic pathways, relative abundance and significantly different operational taxonomic units (OTUs) between ICP and controls were also identified. Results Elevated levels of total bile acid, ALT, AST, Dbil and Tbil were recorded or observed in ICP subjects as compared to the control. Gut microbiota in pregnant women was dominated by four major phyla and 27 core genera. PCoA analysis results indicated that there was no significant clustering in Bray-Curtis distance matrices. Our results showed that there was a correlation between specific OTUs and measured clinical parameters of pregnant women. Comparison at the different taxonomy levels revealed high levels of abundance of Blautia and Citrobacter in ICP patients. At the family level, Enterobacteriaceae and Leuconostocaceae were higher in ICP patients. 638 KEGG Orthologs and 138 pathways significantly differed in the two groups. PLS-DA model with VIP plots indicated a total of eight genera and seven species were key taxa in ICP and control groups. Conclusions Our research indicated that although there was no significant clustering by PCoA analysis, patients with ICP have increased rare bacteria at different phylogenetic levels. Our results also illustrated that all 638 KEGG Orthologs and 136 in 138 KEGG pathways were less abundant in ICP patients compared to the controls.

Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies

An omics review and perspective of researches on intrahepatic cholestasis of pregnancy

A comprehensive review of novel biomarkers in the diagnosis of intrahepatic cholestasis of pregnancy

Unexplored topics in intrahepatic cholestasis of pregnancy: A review and bibliometric analysis

Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy

Current understanding of autophagy in intrahepatic cholestasis of pregnancy

Characterization of Gut Microbiota Associated with Clinical Parameters in Intrahepatic Cholestasis of Pregnancy

Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients

Circulatory Metabolomics Reveals the Association of the Metabolites With Clinical Features in the Patients With Intrahepatic Cholestasis of Pregnancy

Altered gene profile of placenta from women with intrahepatic cholestasis of pregnancy

Placental Gene-Expression Profiles of Intrahepatic Cholestasis of Pregnancy Reveal Involvement of Multiple Molecular Pathways in Blood Vessel Formation and Inflammation

Studies on Novel Diagnostic and Predictive Biomarkers of Intrahepatic Cholestasis of Pregnancy Through Metabolomics and Proteomics

Comprehensive Analysis of Quantitative Proteomics With DIA Mass Spectrometry and ceRNA Network in Intrahepatic Cholestasis of Pregnancy

Increased Serum Levels of Neopterin and Soluble Interleukin-2 Receptor in Intrahepatic Cholestasis of Pregnancy.

Profiles and integration of the gut microbiome and fecal metabolites in severe intrahepatic cholestasis of pregnancy

Identification and validation of diagnostic biomarkers for intrahepatic cholestasis of pregnancy based on untargeted and targeted metabolomics analyses of urine metabolite profiles

Intrahepatic cholestasis of pregnancy: Introduction and overview 2024

Metabolic Changes in Bile Acids with Pregnancy Progression and Their Correlation with Perinatal Complications in Intrahepatic Cholestasis of Pregnant Patients

Intrahepatic cholestasis of pregnancy and maternal dyslipidemia: a systematic review and meta-analysis

Comprehensive analysis of placental gene-expression profiles and identification of EGFR-mediated autophagy and ferroptosis suppression in intrahepatic cholestasis of pregnancy